Further development of medical technologies to advance brain disease diagnoses, treat spinal cord injuries and manage pain without the use of addictive opioids would be key beneficiaries if additional funding from Congress for the National Institutes of Health comes through, NIH head Francis Collins told appropriators.
National Institutes of Health Director Francis Collins and other NIH leaders promised delivery on a 10-point checklist of medical advances – many involving new uses of medical devices – within the next 10 years, but only if Congress increases funding for the agency.
Collins made the case for more funding to House appropriators on March 16. Among the technologies he described to the...
2026 reimbursement calculations for the list of hybrid DRGs – a mechanism to incentivize day cases over inpatient surgery – will be issued in few weeks’ time. The medtech industry has made its demands known.
The FDA's Device Clinical Trial Snapshot Pilot, aimed at increasing trial transparency and diversity, has been canceled following President Trump’s anti-DEI executive order. Critics warn this may hinder trial transparency, impacting public health and demographic data accessibility.
The US FDA posted three warning letters in July, covering medical supply kits, wearables and orthopedics.
